Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

被引：1

作者：

Simpson, Eric L. ^{[1
]}

Silverberg, Jonathan, I ^{[2
]}

Worm, Margitta ^{[3
]}

Honari, Golara ^{[4
]}

Masuda, Koji ^{[5
]}

Sygula, Ewa ^{[6
]}

Maloney, Jennifer ^{[7
]}

Mannent, Leda P. ^{[8
]}

Xiao, Jing ^{[7
]}

Dubost-Brama, Ariane ^{[8
]}

Bansal, Ashish ^{[7
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR USA

[2] George Washington Sch Med & Hlth Sci, Washington, DC USA

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Stanford Univ, Sch Med, Redwood City, CA USA

[5] Kyoto Prefectural Univ Med, Kyoto, Japan

[6] Andrzej Mielecki Mem Independent Publ Clin Hosp, Katowice, Poland

[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[8] Sanofi, Chilly Mazarin, France

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

dupilumab; moderate-to-severe; hand; foot; dermatitis;

D O I：

10.1093/bjd/ljad162.029

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

408

引用

页数：2

共 50 条

[1] Efficacy of dupilumab treatment in atopic hand and foot dermatitis across morphological subtypes: results from a phase 3, randomized, double-blind, placebo-controlled trial
Worm, Margitta
Simpson, Eric L.
Honari, Golara
Soong, Weily
Pinter, Andreas
Masuda, Koji
Shao, Liyang
Dubost-Brama, Ariane
Bansal, Ashish
Korotzer, Andrew
Rossi, Ana B.
BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II60 - II60
[2] Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Simpson, Eric L.
Silverberg, Jonathan I.
Worm, Margitta
Honari, Golara
Masuda, Koji
Sygu, Ewa
Schuttelaar, Marie L. A.
Mortensen, Eric
Laws, Elizabeth
Akinlade, Bolanle
Patel, Naimish
Maloney, Jennifer
Paleczny, Heather
Delevry, Dimittri
Xiao, Jing
Dubost-Brama, Ariane
Bansal, Ashish
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1190 - 1199
[3] Dupilumab pharmacokinetics in Chinese healthy subjects and patients with atopic dermatitis: Results of two randomized, double-blind, placebo-controlled studies
Clot, Pierre-Francois
Kamal, Mohamed
Sun, Jing
Xu, Christine
Kong, Fangyuan
Gu, Yongzhen
Yang, Na
Yin, WeiHong
Chen, Bing
Ming, Jeffrey E.
Yuan, Yaozong
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
[4] Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study
Ebisawa, Motohiro
Kataoka, Yoko
Tanaka, Akio
Nagao, Mizuho
Laws, Elizabeth
Mortensen, Eric
Nawata, Hisakatsu
Arima, Kazuhiko
Watanabe, Daisuke
Lu, Xin
Maloney, Jennifer
Dubost-Brama, Ariane
Bansal, Ashish
Yahata, Kenji
ALLERGOLOGY INTERNATIONAL, 2024, 73 (04) : 532 - 542
[5] Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
Langer, Sarah Sella
Cardili, Renata Nahas
Lima Melo, Janaina Michelle
Leme Ferriani, Mariana Paes
Moreno, Adriana Santos
Dias, Marina Mendonca
Bueno-Filho, Roberto
Candido Pocente, Renata Helena
Roxo-Junior, Persio
Silva, Jorgete
Pereira Valera, Fabiana Cardoso
Coelho, Eduardo Barbosa
Santos Galvao, Clovis Eduardo
Carmona, Fabio
Aragon, Davi Casale
Arruda, Luisa Karla
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 539 - +
[6] Efficacy and Safety of GR1802 in Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Wang, Shangshang
Zhang, Litao
Liang, Yunsheng
Zhang, Shifa
Wang, Jingyan
Man, Xiaoyong
Ji, Chao
Chen, Rixin
Xiang, Guang
Meng, Zudong
Yang, Chunjun
Cheng, Hao
Wang, Qi
Li, Lin-feng
Zhang, Siping
Ding, Yanfeng
Zhu, Quangang
Qin, Lanying
Li, Yumei
Lu, Qianjin
Xia, Li
Cao, Shuanglin
Yu, Chunshui
Duan, Xinsuo
Wu, Liming
Zhang, Chunlei
Jiang, Congjun
Wang, Wei
Xu, Jinhua
DERMATOLOGIC THERAPY, 2025, 2025 (01)
[7] Synbiotics could not Reduce the Scoring of Childhood Atopic Dermatitis (SCORAD): A Randomized Double Blind Placebo-Controlled Trial
Shafiei, Alireza
Moin, Mostafa
Pourpak, Zahra
Gharagozlou, Mohammad
Aghamohamadi, Asghar
Sajedi, Vahid
Soheili, Habib
Sotoodeh, Soheila
Movahedi, Masoud
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2011, 10 (01) : 21 - 28
[8] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
Merola, Joseph F.
Parish, Lawrence Charles
Guenther, Lyn
Lynde, Charles
Lacour, Jean -Philippe
Staubach, Petra
Cheng, Sue
Paris, Maria
Picard, Hernan
Deignan, Cynthia
Jardon, Shauna
Chen, Mindy
Papp, Kim A.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
[9] The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study
Shin, Kichul
Kim, Joon Wan
Moon, Ki Won
Yang, Ji Ae
Lee, Eun Yeong
Song, Yeong Wook
Lee, Eun Bong
CLINICAL THERAPEUTICS, 2013, 35 (04) : 431 - 439
[10] Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
Maurer, Marcus
Casale, Thomas B.
Saini, Sarbjit S.
Ben-Shoshan, Moshe
Gimenez-Arnau, Ana M.
Bernstein, Jonathan A.
Yagami, Akiko
Stjepanovic, Aleksandra
Radin, Allen
Staudinger, Heribert W.
Patel, Naimish
Amin, Nikhil
Akinlade, Bolanle
Fan, Chunpeng
Bauer, Deborah
Yancopoulos, George D.
Patel, Kiran
Mannent, Leda P.
Laws, Elizabeth
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (01) : 184 - 194

← 1 2 3 4 5 →